Trial Profile
A phase I study of paclitaxel (Taxol) administered on a twice-weekly schedule to children with recurrent or refractory solid tumours
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 23 Dec 2005
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 23 Dec 2005 New trial record.